NIH-funded research U01 cooperative agreement

Understanding immune responses to malaria vaccination

Official title: Collective Responses to Malaria Vaccination

Funded at Seattle Children's Hospital · NIH-11016925 · Data updated 2026-11-12

This study is looking at how the immune system reacts to a malaria vaccine made from weakened parasites, and it's for people who want to help researchers understand what makes the vaccine work better for those who have and haven't had malaria before.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionSeattle Children's Hospital
NIH-funded
Lab location1 site (Seattle, United States)
Project startFebruary 9, 2022
Project endJanuary 31, 2027
Funding year2025
Award (this year)$679,001
NIH project number5U01AI165455-04
Project IDNIH-11016925 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are either malaria-naïve or have experienced malaria and are willing to participate in vaccination trials.

Less likely to help

Patients who are not interested in malaria vaccination or those with severe immune system disorders may not benefit from this research.

What this research studies

This research investigates how the immune system responds to a malaria vaccine made from weakened malaria parasites. By analyzing blood samples from individuals who have received the vaccine, researchers aim to identify specific immune responses that lead to protection against malaria. The study will use advanced techniques to track both the cellular and antibody responses over time, focusing on how these responses differ between people who have never had malaria and those who have. The goal is to uncover the key immune characteristics that contribute to effective vaccination.

Why it matters

Potential benefit: If successful, this research could lead to more effective malaria vaccines that provide long-lasting immunity.

How similar studies have gone: Previous research has shown promising results in understanding immune responses to other vaccines, suggesting that this approach could yield valuable insights for malaria vaccination.

Where this research is happening

  • Seattle Children's Hospital
    Seattle, United States
    Active

Researchers

  • Principal investigator: Stuart, Kenneth D — Seattle Children's Hospital
  • Study coordinator: Stuart, Kenneth D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.